Department of Neurology

Victor M. Rivera, M.D.

Professor of Neurology
Medical Director, Maxine Mesinger MS Clinic

 

Clinical Service Area

Neurology - Neurology

Specialty

Multiple Sclerosis

Board Certification

American Board of Psychiatry and Neurology, Neurology

Clinic Appointments

713-798-7707

Consult

713-798-7707

Medical School

Universidad Nacional Autonoma, Mexico City , Mexico

Internship

Manchester Memorial Hospital, Manchester, CT

Residency

Neurology, Baylor College of Medicine, Houston, TX

Clinical Interests

Multiple Sclerosis and demyelinating diseases, cerebral and spinal vascular disorders, general neurology

Clinic Location

Maxine Mesinger Multiple Sclerosis Clinic
Neurosensory Building
6501 Fannin, NB 100
Houston, TX 77030

Publications

• Cristiano E, Arcega R, Correale J, Gabbay AA, Lander-Delgado R, Macias-Islas MA, Palacios E, Patrucco L, Rivera-Olmos V, Soto A. [Recommendations for optimising the treatment of multiple sclerosis in Latin America]. Rev Neurol 2007;44:494-8.
• Ordonez L, Skromne E, Ontaneda D, Rivera VM. Multiphasic disseminated encephalomyelitis, systemic lupus erythematosus and antiphospholipid syndrome. Clin Neurol Neurosurg 2007;109:102-5.
• Rivera-Olmos VM, Avila MC. Esclerosis Múltiple en Latinoamérica. ¿Son los criterios de McDonald realmente aplicables?. Rev Mex Neuroci 2007;8:49-56.
• Carra A, Rivera-Olmos V, Arcega R, Gabbai A, Haussen SR, Luetic G, San Pedro E, Tenembaum S. [The treatment of multiple sclerosis in Latin America: current practice and optimal standards. The findings of a survey among neurologists at an interactive workshop]. Rev Neurol 2006;42:399-407.
• Rivera-Olmos VM, Landero S. Multiple Sclerosis in Mexican American Population. Int J MS Care 2006;7:143-7.
• Skromne E, Rivera VM, Ontaneda D, Ordonez L. Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon. Neurology 2006;66:1787-8; author reply 1787-8.
• Skromne-Eisenberg E, Rivera-Olmos VM, Ordoñez-Boschetti L, Ontaneda-Johnson D. Trasplante de células madre hematopoyéticas en esclerosis multiple. Actualidades y futuro en su uso y selección de pacientes. Rev Mex Neuroci 2006;7:164-9.
• Rivera VM. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology 2005;64:2163.
• Rivera VM. Modafinil for the treatment of diminished responsiveness in a patient recovering from brain surgery. Brain Inj 2005;19:725-7.
• Rivera VM. The terms Latino and Anglo and tendency to early Alzheimer disease. Arch Neurol 2005;62:1787; author reply 1787-8.
• Rivera-Olmos VM, Lozano JA. Síndrome de Cogan: manifestaciones neurológicas. Reporte de caso y revisión de la bibliografía. Rev Mex Neuroci 2005;6:97-101.
• Hong J, Zang YC, Hutton G, Rivera VM, Zhang JZ. Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis. J Neuroimmunol 2004;152:126-39.
• Hong J, Zang YC, Li S, Rivera VM, Zhang JZ. Ex vivo detection of myelin basic protein-reactive T cells in multiple sclerosis and controls using specific TCR oligonucleotide probes. Eur J Immunol 2004;34:870-81.
• Rivera VM. Esclerosis Multiple: Evidencias, genericos y similares. Rev Mex Neuroci 2004;5:286-7.
• Rivera-Olmos VM, Hutton GJ, Breitbach WT. Discrepancia entre clínica e imagen: esclerosis múltiple en fase intermedia. Presentación de un caso y revisión del tema. Rev Mex Neuroci 2004;5:158-62.
• Zang YC, Li S, Rivera VM, Hong J, Robinson RR, Breitbach WT, Killian J, Zhang JZ. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis. J Immunol 2004;172:5120-7.
• Zang YC, Skinner SM, Robinson RR, Li S, Rivera VM, Hutton GJ, Zhang JZ. Regulation of differentiation and functional properties of monocytes and monocyte-derived dendritic cells by interferon beta in multiple sclerosis. Mult Scler 2004;10:499-506.
• Frohman EM, Goodin DS, Calabresi PA, Corboy JR, Coyle PK, Filippi M, Frank JA, Galetta SL, Grossman RI, Hawker K, Kachuck NJ, Levin MC, Phillips JT, Racke MK, Rivera VM, Stuart WH. The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003;61:602-11.
• Frohman TC, Frohman EM, O'Suilleabhain P, Salter A, Dewey RB, Jr., Hogan N, Galetta S, Lee AG, Straumann D, Noseworthy J, Zee D, Corbett J, Corboy J, Rivera VM, Kramer PD. Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography. Neurology 2003;61:848-50.
• Rivera VM. [Deciding on treatment in Multiple Sclerosis]. Rev Neurol 2003;36:80-5.
• Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Zhang JZ. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol 2003;53:189-97.
• Velazquez-Quintana M, Macias-Islas MA, Rivera-Olmos V, Lozano-Zarate J. [Multiple sclerosis in Mexico: a multicentre study]. Rev Neurol 2003;36:1019-22.
• Zang Y, Hong J, Robinson R, Li S, Rivera VM, Zhang JZ. Immune regulatory properties and interactions of copolymer-I and beta-interferon 1a in multiple sclerosis. J Neuroimmunol 2003;137:144-53.
• Zang YC, Hong J, Rivera VM, Killian J, Zhang JZ. Human anti-idiotypic T cells induced by TCR peptides corresponding to a common CDR3 sequence motif in myelin basic protein-reactive T cells. Int Immunol 2003;15:1073-80.
• Hong J, Tejada-Simon MV, Rivera VM, Zang YC, Zhang JZ. Anti-viral properties of interferon beta treatment in patients with multiple sclerosis. Mult Scler 2002;8:237-42.
• Rivera VM. II Congreso de LACTRIMS. Rev Neurol 2002;35:1175-6.
• Tejada-Simon MV, Hong J, Rivera VM, Zhang JZ. Skewed autoantibody reactivity to the extracellular domain of myelin oligodendrocyte glycoprotein in multiple sclerosis. Immunology 2002;107:403-10.
• Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Killian JM, Zhang JZ. Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J Virol 2002;76:6147-54.
• Zang YC, Halder JB, Hong J, Rivera VM, Zhang JZ. Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa B. J Neuroimmunol 2002;124:106-14.
• Zhang JZ, Rivera VM, Tejada-Simon MV, Yang D, Hong J, Li S, Haykal H, Killian J, Zang YC. T cell vaccination in multiple sclerosis: results of a preliminary study. J Neurol 2002;249:212-8.
• Ciancio SJ, Mutchnik SE, Rivera VM, Boone TB. Urodynamic pattern changes in multiple sclerosis. Urology 2001;57:239-45.
• Rivera VM. La Decada del Cerebro. Neurociencia 2001;2:131.
• Rivera VM. [Neuroimaging in multiple sclerosis]. Rev Neurol 2001;32:283-5.
• Rivera VM. [Pharmacologic treatment of multiple sclerosis]. Rev Neurol 2001;32:285-8.
• Rivera VM, Cabrera JA. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica. Neurology 2001;57:937-8.
• Tejada-Simon MV, Hong J, Rivera VM, Zhang JZ. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals. Eur J Immunol 2001;31:907-17.
• Zang YC, Halder JB, Samanta AK, Hong J, Rivera VM, Zhang JZ. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta. J Neuroimmunol 2001;112:174-80.
• Hong J, Zang YC, Tejada-Simon MV, Li S, Rivera VM, Killian J, Zhang JZ. Reactivity and regulatory properties of human anti-idiotypic antibodies induced by T cell vaccination. J Immunol 2000;165:6858-64.
• Rivera VM. Grupo de Estudio de EM (Mexico): Uso de Agentes Modificadores de la Enfermedad. Neurociencia 2000;3:29-30.
• Rivera VM. Introduccion al Simposio Latinoamericano. Rev Neurol 2000;31:469.
• Rivera VM. [The treatment of multiple sclerosis with beta-interferon 1a]. Rev Neurol 2000;31:470-1.
• Rivera VM, Cabrera JA. La Esclerosis Multiple en Latino America. MEDICO Interamericano 2000;19:458-65.
• Tejada-Simon MV, Zang YC, Yang D, Hong J, Li S, Singh RA, Van den Berg-Loonen E, Killian JM, Rivera VM, Zhang JZ. Aberrant T cell responses to myelin antigens during clinical exacerbation in patients with multiple sclerosis. Int Immunol 2000;12:1641-50.
• Zang YC, Hong J, Rivera VM, Killian J, Zhang JZ. Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination. J Immunol 2000;164:4011-7.
• Zang YC, Hong J, Tejada-Simon MV, Li S, Rivera VM, Killian JM, Zhang JZ. Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis. Eur J Immunol 2000;30:908-13.
• Zang YC, Samanta AK, Halder JB, Hong J, Tejada-Simon MV, Rivera VM, Zhang JZ. Aberrant T cell migration toward RANTES and MIP-1 alpha in patients with multiple sclerosis. Overexpression of chemokine receptor CCR5. Brain 2000;:1874-82.
• Zang YC, Yang D, Hong J, Tejada-Simon MV, Rivera VM, Zhang JZ. Immunoregulation and blocking antibodies induced by interferon beta treatment in MS. Neurology 2000;55:397-404.
• Hong J, Zang YC, Tejada-Simon MV, Kozovska M, Li S, Singh RA, Yang D, Rivera VM, Killian JK, Zhang JZ. A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis. J Immunol 1999;163:3530-8.
• Kil K, Zang YC, Yang D, Markowski J, Fuoco GS, Vendetti GC, Rivera VM, Zhang JZ. T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis. J Neuroimmunol 1999;98:201-7.
• Kozovska ME, Hong J, Zang YC, Li S, Rivera VM, Killian JM, Zhang JZ. Interferon beta induces T-helper 2 immune deviation in MS. Neurology 1999;53:1692-7.
• Singh RA, Zang YC, Shrivastava A, Hong J, Wang GT, Li S, Tejada-Simon MV, Kozovska M, Rivera VM, Zhang JZ. Th1 and Th2 deviation of myelin-autoreactive T cells by altered peptide ligands is associated with reciprocal regulation of Lck, Fyn, and ZAP-70. J Immunol 1999;163:6393-402.
• Zang YC, Kozovska MM, Hong J, Li S, Mann S, Killian JM, Rivera VM, Zhang JZ. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis. Eur J Immunol 1999;29:1692-700.
• Kozovska M, Zang YC, Aebischer I, Lnu S, Rivera VM, Crowe PD, Boehme SA, Zhang JZ. T cell recognition motifs of an immunodominant peptide of myelin basic protein in patients with multiple sclerosis: structural requirements and clinical implications. Eur J Immunol 1998;28:1894-901.
• Zang YC, Kozovska M, Aebischer I, Li S, Boehme S, Crowe P, Rivera VM, Zhang JZ. Restricted TCR Valpha gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis. Int Immunol 1998;10:991-8.
• Jerger J, Alford B, Lew H, Rivera V, Chmiel R. Dichotic listening, event-related potentials, and interhemispheric transfer in the elderly. Ear Hear 1995;16:482-98.
• Trujillo JR, Garcia-Ramos G, Novak IS, Rivera VM, Huerta E, Essex M. Neurologic manifestations of AIDS: a comparative study of two populations from Mexico and the United States. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:23-9.
• Safi HJ, Bartoli S, Hess KR, Shenaq SS, Viets JR, Butt GR, Sheinbaum R, Doerr HK, Maulsby R, Rivera VM. Neurologic deficit in patients at high risk with thoracoabdominal aortic aneurysms: the role of cerebral spinal fluid drainage and distal aortic perfusion. J Vasc Surg 1994;20:434-44; discussion 442-3.
• Crawford ES, Svensson LG, Hess KR, Shenaq SS, Coselli JS, Safi HJ, Mohindra PK, Rivera V. A prospective randomized study of cerebrospinal fluid drainage to prevent paraplegia after high-risk surgery on the thoracoabdominal aorta. J Vasc Surg 1991;13:36-45; discussion 45-6.
• Mawad ME, Rivera V, Crawford S, Ramirez A, Breitbach W. Spinal cord ischemia after resection of thoracoabdominal aortic aneurysms: MR findings in 24 patients. AJR Am J Roentgenol 1990;155:1303-7.
• Rivera VM. Safety of intrathecal steroids in multiple sclerosis. Arch Neurol 1989;46:718-9.
• Jerger JF, Oliver TA, Chmiel RA, Rivera VM. Patterns of auditory abnormality in multiple sclerosis. Audiology 1986;25:193-209.
• Rivera VM. Multiple sclerosis. Is the mystery beginning to unfold?. Postgrad Med 1986;79:217-32.
• Hannley M, Jerger JF, Rivera VM. Relationships among auditory brain stem responses, masking level differences and the acoustic reflex in multiple sclerosis. Audiology 1983;22:20-33.
• Rivera VM. Intraspinal steroid therapy. Neurology 1981;31:1060-1.
• Rivera VM, Grabois M, Deaton W, Breitbach W, Hines M. Modified snake venom in amyotrophic lateral sclerosis. Lack of clinical effectiveness. Arch Neurol 1980;37:201-3.
• Jankovic J, Rivera VM. Hereditary myoclonus and progressive distal muscular atrophy. Ann Neurol 1979;6:227-31.
• Jankovic J, Rivera V. Hereditary myoclonus and progressive muscular atrophy: a new syndrome. Trans Am Neurol Assoc 1978;103:116-8.
• Perez FI, Hruska NA, Stell RL, Rivera VM. Computerized assessment of memory performance in dementia. Can J Neurol Sci 1978;5:307-12.
• Rivera VM. Acute hypokalemic myopathy in alcoholism. Arch Neurol 1978;35:619.
• Rivera VM, Patten BM. Neuromyopathy in malignant hyperthermia. J Clin Psychiatry 1978;39:67-71.
• Guido EM, Rivera VM. Precordialgia as a manifestation of vertebrobasilar insufficiency. J Am Geriatr Soc 1977;25:463-5.
• Rivera VM. Viruses and multiple sclerosis. Jama 1977;238:1247.
• Rodriguez J, Rivera VM. Risk factors in stroke in a Mexican-American population (Houston). Neurol Neurocir Psiquiatr 1977;18:225-34.
• Perez FI, Gay JR, Taylor RL, Rivera VM. Patterns of memory performance in the neurologically impaired aged. Can J Neurol Sci 1975;2:347-55.
• Perez FI, Rivera VM, Meyer JS, Gay JR, Taylor RL, Mathew NT. Analysis of intellectual and cognitive performance in patients with multi-infarct dementia, vertebrobasilar insufficiency with dementia, and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1975;38:533-40.
• Rivera VM, Breitbach WB, Swanke L. Letter: Dantrolene in amyotrophic lateral sclerosis. Jama 1975;233:863-4.
• Rivera VM, Keichian AH, Oliver RE. Persistent parkinsonism following neuroleptanalgesia. Anesthesiology 1975;42:635-7.
• Meyer JS, Bauer RB, Rivera-Olmos VM, Nolan DC, Lerner AM. Herpesvirus hominis encephalitis. Neurological manifestations and use of idoxuridine. Arch Neurol 1970;23:438-50.

Poster Presentations

• Suarez-Zambrano GA, Pena JA, Avila M, Hutton GJ, Rivera VM. Frequency and Severity of Restless Legs Syndrome in Multiple Sclerosis: A Population Study from Southeast Texas. American Academy of Neurology (AAN), 60th Annual Meeting in Chicago, Illinois (April 12-19, 2008).
• Avila M, Ramirez J, Suárez-Zambrano GA, Hutton GJ, Rivera VM. Multiple Sclerosis and Antiphospholipid Syndrome: Case Report. Mexican Academy of Neurology, 31st Annual Meeting in Monterrey, Mexico (Oct. 31 - Nov. 5, 2007).
• Avila M, Suárez-Zambrano GA, Ramirez J, Hutton GJ, Rivera VM. Encefalomielitis Diseminada Recurrente y Multifásica Reporte de 2 Casos. Mexican Academy of Neurology, 31st Annual Meeting in Monterrey, Mexico (Oct. 31 - Nov. 5, 2007). [Recurrent Disseminated Encephalomyelitis: Report of 2 Cases]
• Suárez-Zambrano GA, Escobar BH, Avila M, Ramirez J, Hutton GJ, Rivera VM. Experience with Natalizumab in a Group of MS Patients from Southeast Texas. Mexican Academy of Neurology, 31st Annual Meeting in Monterrey, Mexico (Oct. 31 - Nov. 5, 2007).
• Hutton GJ, Avila M, Suárez-Zambrano GA, Ramirez J, Rivera VM. Recurrent Disseminated Encephalomyelitis: Report of 2 Cases. European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 23rd Congress in Prague, Czech Republic (Oct. 11-14, 2007).
• Hutton GJ, Suárez-Zambrano GA, Jafree I, Landero S, Avila M, Rivera VM. Is Restless Legs Syndrome More Frequent and Severe in the Multiple Sclerosis Population? Study in Multiple Sclerosis Patients from Southeast Texas. European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 23rd Congress in Prague, Czech Republic (Oct. 11-14, 2007).
• Suárez-Zambrano GA, Avila M, Landero S, Jafree I, Escobar BH, Ramírez J, Brandt D, Hutton GJ, Rivera VM. Experiencia con Natalizumab en 40 Pacientes con Esclerosis Multiple Exacerbacion Remision. Colombian Academy of Neurology, VIII Meeting in Cali, Colombia (Aug. 16-19, 2007).
• Jafree I, Hashmi K, Landero S, Suarez G, Hutton GJ, Rivera VM. Multiple Sclerosis and Other Autoimmune Diseases. Consortium of Multiple Sclerosis Centers (CMSC), 21st Annual Meeting in Washington, DC (May 30 - June 2, 2007).
• Landero S, Rivera VM, Hutton GJ, Suárez-Zambrano GA, Ramirez J. Behavior of Multiple Sclerosis during Pregnancy and after Delivery. Consortium of Multiple Sclerosis Centers (CMSC), 21st Annual Meeting in Washington, DC (May 30 - June 2, 2007).
• Suárez-Zambrano GA, Landero S, Jafree I, Hutton GJ, Rivera VM. Frequency and Severity of Restless Legs Syndrome in MS Patients from Southeast Texas. Consortium of Multiple Sclerosis Centers (CMSC), 21st Annual Meeting in Washington, DC (May 30 - June 2, 2007).
• Suárez-Zambrano GA, Landero S, Jafree I, Hutton GJ, Rivera VM. Multiple Sclerosis in African Americans: A Cohort from Southeast Texas. Consortium of Multiple Sclerosis Centers (CMSC), 21st Annual Meeting in Washington, DC (May 30 - June 2, 2007).
• Suárez-Zambrano GA, Perez F, Avila M, Hutton GJ, Rivera VM. Computer-Assisted Cognitive Rehabilitation in Patients with Multiple Sclerosis. Consortium of Multiple Sclerosis Centers (CMSC), 21st Annual Meeting in Washington, DC (May 30 - June 2, 2007).
• Rivera VM, Al-Sabbagh A, Bennett R, Coyle P, Mikol D, Panitch H, Fox E, Rolak L, Sheremata W, Elias S. Ongoing Evaluation of the Safety and Tolerability of Mitoxantrone in Worsening Multiple Sclerosis: The RENEW Study. American Academy of Neurology (AAN), 59th Annual Meeting in Boston, Massachusetts (April 28 - May 5, 2007).
• Suárez-Zambrano GA, Pérez F, Avila M, Hutton GJ, Rivera VM. Rehabilitación Cognitiva Asistida por Computadora en Pacientes con Esclerosis Múltiple. Mexican Academy of Neurology, 30th Annual Meeting in Merida, Yucatan, Mexico (Oct. 30 - Nov. 4, 2006).
• Ordoñez L, Skromne E, Rivera-Olmos VM. Caracterizacion de Sindromes Clinicos de Comportamiento Similar a Esclerosis Multiple . Mexican Academy of Neurology, 29th Annual Meeting in Chihuahua, Mexico (Oct. 29 - Nov. 3, 2005).

Contact Information

Victor M. Rivera, M.D.
Department of Neurology
Baylor College of Medicine
One Baylor Plaza, MS NB302
Houston, Texas 77030

Tel: 713-798-6296
Fax: 713-798-6273
Email:

• Home
• Patients & Visitors
• Clinical Programs
  • Autonomic Function
  • EMG/NCV
  • Epilepsy
  • Medical Neuromuscular
  • Memory & Dementia
  • Multiple Sclerosis
  • Neurogenetics
  • Parkinson’s & Movement Disorders
  • Sleep
  • Vascular Neurology
• Research Programs
  • Neurobiology
  • Neuroimmunology
  • Parkinson’s & Movement Disorders
• Education
  • Overview
  • BCM
    Medical Students
  • National & International Students
  • Residency in
    Adult Neurology
  • Residency in
    Pediatric Neurology
  • Residency Training in Neurology
    Slide Show
  • Clinical & Research Fellowships
  • Application Process
  • Clinical Neuroscience
    Grand Rounds
  • Neurology Seminars
  • Case of the Month
• Faculty
  • Neurology
  • Pediatric Neurology
  • Adjunct/Voluntary
  • Publications
  • Poster Presentations
  • Activities
• Calendar
  • Seminars & Rounds
  • Administration*
  • On-Call Schedule*
  • Past News & Events
• About Us
  • Neurology Yearbook
  • Texas Medical Center
• Help Us
  In Our Mission
• Links & Resources
• Resources
  *(BCM login required)
• Contact Us
  • Contact Neurology
  • Baylor Secure Messaging
  • BIGFILE Upload
  • Maps & Directions
• Site Map